Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background The symptoms of irritable bowel syndrome (IBS) lead to considerable impairment of health-related quality of life and high health care costs. Available therapies are not efficient in treating the symptoms of IBS. Studies have shown the beneficial effects of Saccharomyces cerevisiae CNCM I-3856. Therefore, this study was done to evaluate the efficacy and safety of S. cerevisiae CNCM I-3856 in the treatment of IBS. Methods This was a prospective, randomized, placebo-controlled study. One hundred newly diagnosed subjects with IBS were subgrouped into IBS-D, IBS-C, and IBS-M and then randomized to the S. cerevisiae CNCM I-3856 and placebo groups. Saccharomyces cerevisiae/placebo was administered in addition to standard treatment for a period of 8 weeks. Subjects were assessed for improvement of abdominal pain and change in stool consistency using a 7-point Likert scale and Bristol stool scale respectively. Results The mean reduction of abdominal pain score in the S. cerevisiae CNCM I-3856 group was statistically significant when compared with the placebo group (p Conclusion The use of Saccharomyces cerevisiae CNCM I-3856 in IBS at a dose of 2 billion CFU twice daily for 8 weeks has shown to have an improvement in abdominal pain and stool consistency due to its analgesic and anti-inflammatory activity in subjects with IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the abdominal pain outcomes, we consider that Gayathri’s study [58] administered standard IBS therapy (antispasmodic dicyclomine) for two weeks along with a placebo twice daily for eight weeks during the trial, which might be a major source of heterogeneity in the analysis.”
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
The epidemiology of irritable bowel syndrome
Card, T., Canavan, C., & West, J. (2014) · Clinical Epidemiology · doi:10.2147/clep.s40245 · Cited by 889
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Lovell, R. M., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.131 · Cited by 412
Ghoshal, U. C., Abraham, P., Bhatt, C. B., Choudhuri, G., Bhatia, S. J., Shenoy, K. T., Banka, N. H., Bose, K. S. C., Bohidar, N. P., Chakravartty, K., et al. (2008) · PubMed · Cited by 193
Symptoms across the menstrual cycle in women with irritable bowel syndrome
Heitkemper, M. M., Cain, K. C., Jarrett, M. E., Burr, R. L., Hertig, V., & Bond, E. F. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07233.x · Cited by 165
Short-Chain Fatty Acids Stimulate Ileal Motility in Humans
Kamath, P. S., Phillips, S. F., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80068-4 · Cited by 158
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135
Pineton de Chambrun, G., Neut, C., Chau, A., Cazaubiel, M., Pelerin, F., Justen, P., & Desreumaux, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.007 · Cited by 120
Jawhara, S., Habib, K., Maggiotto, F., Pignede, G., Vandekerckove, P., Maes, E., Dubuquoy, L., Fontaine, T., Guerardel, Y., & Poulain, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040648 · Cited by 113
Cited by
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
Wu, X., Xia, Y., He, F., Zhu, C., & Ren, W. (2021) · Microbiome · doi:10.1186/s40168-021-01024-x · Cited by 162
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859967 · Cited by 125
McFarland, L. V., Karakan, T., & Karataş, A. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101154 · Cited by 108
Napolitano, M., Fasulo, E., Ungaro, F., Massimino, L., Sinagra, E., Danese, S., & Mandarino, F. V. (2023) · Microorganisms · doi:10.3390/microorganisms11102369 · Cited by 107
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients
Sciavilla, P., Strati, F., Paola, M. D., Modesto, M., Vitali, F., Cavalieri, D., Prati, G. M., Vito, M. D., Aragona, G., Filippo, C. D., et al. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11264-4 · Cited by 76
Gaziano, R., Sabbatini, S., Roselletti, E., Perito, S., & Monari, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00718 · Cited by 70
Loh, L. X., Ng, D., Toh, M., Lu, Y., & Liu, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03992 · Cited by 66
Wielgosz-Grochowska, J. P., Domański, N., & Drywień, M. E. (2022) · Nutrients · doi:10.3390/nu14163382 · Cited by 61
Xie, P., Luo, M., Deng, X., Fan, J., & Xiong, L. (2023) · Nutrients · doi:10.3390/nu15173856 · Cited by 50
Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41
“Gayathri 2019 [58] India 100 (52/48) 24 (12/12) Rome III S.”
BackgroundMethodInfluentialChen, M., Lu, Y., Xie, C.-R., Wang, X., Feng, S., Xiao, X.-Y., & Zheng, H. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000658 · Cited by 40
Xie, C.-R., Tang, B., Shi, Y., Peng, W.-Y., Ye, K., Tao, Q., Yu, S., Zheng, H., & Chen, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853011 · Cited by 34
The role of the gut microbiome in disorders of gut–brain interaction
Gawey, B. J., Mars, R. A. T., & Kashyap, P. (2024) · FEBS Journal · doi:10.1111/febs.17200 · Cited by 32
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
Mourey, F., Decherf, A. C., Jeanne, J.-F., Clément‐Ziza, M., Grisoni, M.-L., Machuron, F., Legrain–Raspaud, S., Bourreille, A., & Desreumaux, P. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i22.2509 · Cited by 32
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold
Compare, D., Sgamato, C., Nardone, O. M., Rocco, A., Coccoli, P., Laurenza, C., & Nardone, G. (2021) · Digestive Diseases · doi:10.1159/000516023 · Cited by 25
Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome
Liu, A., Gao, W., Zhu, Y., Hou, X., & Chu, H. (2022) · Toxins · doi:10.3390/toxins14090596 · Cited by 19
Maslennikov, R. V., Gosteeva, E., Ananeva, V., Korshunova, L., Kravtsowa, A., Poluektova, E., Ulyanin, A. I., Sigidaev, A. S., Kikhasurova, P. M., & Ivashkin, V. T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031152 · Cited by 15
Szota, M., Napiórkowska-Baran, K., Wojtkiewicz, A., Wydeheft, L., Wawrzeńczyk, A., Sławatycki, J., Treichel, P., Alska, E., Zyśk, B., & Pałgan, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104527 · Cited by 12
Dietary interventions and irritable bowel syndrome – what really works?
Blaga, T. S., Cozma-Petruț, A. P., & Dumitrascu, D. L. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000706 · Cited by 11
Impact of the host microbiota on fungal infections: New possibilities for intervention?
Chow, E. W. L., Pang, L. M., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114896 · Cited by 11
Moazzam, S. W., Mobeen, A., & Siddiqui, M. A. (2022) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2022.04.004 · Cited by 10
Valibouze, C., Speca, S., Dubuquoy, C., Mourey, F., M'Ba, L., Schneider, L., Titécat, M., Foligné, B., Genin, M., Neut, C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i5.851 · Cited by 9
Traynard, V. (2024) · Nutrients · doi:10.3390/nu16223927 · Cited by 5
Saccharomyces and Their Potential Applications in Food and Food Processing Industries
Leo, V. V., Viswanath, V., Deka, P., Zothanpuia, Z., Ramji, D. R., Pachuau, L., Carrie, W., Malvi, Y., Singh, G., & Singh, B. P. (2021) · Fungal biology · doi:10.1007/978-3-030-67561-5_12 · Cited by 5
Almalki, L. A., Jaafari, N. Y., Aldossari, N. G., Alharbi, L. A., Alrdeeni, A. A., Alshareef, A. A., Al-Subhi, A. F. M., Alsubhi, A. F., Alsubhi, M. S., & Almaqhawi, A. (2025) · Medicina · doi:10.3390/medicina62010089 · Cited by 4
Campos, L. L., de Oliveira, S. R. M., Amaral, M. N. S., Gallotti, B., Oliveira, A. F., Arantes, R. M. E., Béla, S. R., Vital, K. D., Fernandes, S. O. A., Cardoso, V. N., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10359-4 · Cited by 3
Potokiri, A., Omeiza, N. A., Ajayi, A. M., Adeleke, P. A., Alagbonsi, A. I., & Iwalewa, E. O. (2024) · Current Research in Physiology · doi:10.1016/j.crphys.2024.100132 · Cited by 3
Liu, J., Xu, W., Xia, B., He, Y., Huang, S., & Zhao, J. (2025) · Protein Expression and Purification · doi:10.1016/j.pep.2025.106827 · Cited by 2
The Role of Yeast Probiotics in Gastrointestinal Conditions: An Overview
Puri, A. S. (2023) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0235 · Cited by 2
Saccharomyces cerevisiae for abdominal pain and discomfort in irritable bowel syndrome patients
Siyal, M., Abbas, Z., Amir, M. R., & Qadeer, M. A. (2023) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.40.3.8349 · Cited by 1
길범주 (2023) · Seoul National University Open Repository (Seoul National University) · Cited by 1
Angry Gut: Irritable Bowel Syndrome
Rajput, I. S., Zaidi, S. I. H., Jaffri, M. S. A., Hasib, S. W., & Razaq, K. (2022) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2021112
Efectividad de los Probióticos en el Tratamiento de Diarrea y Síndrome de Intestino Irritable
Cherres, A. J. R., Prado, N. S. R., & Andrade, C. A. S. (2025) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v9i3.18231
Saccharomyces boulardii as an emerging alternative to bacterial probiotics: A comprehensive review
Kumar, V., Sheikh, M. A., Devi, N., Dahiya, B., Ayyagari, A., Chaudhari, D. N., & Ahire, J. J. (2026) · Gut Microbiology · doi:10.1016/j.gutmic.2026.100019
Koper, J. E. B., Ghyselinck, J., Meulebroek, L. V., Duysburgh, C., Chabrand, L., Machuron, F., Mourey, F., Marzorati, M., & Bosco, N. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120894
Xie, C.-R., Tang, B., Shi, Y.-Z., Peng, W.-Y., Ye, K., Tao, Q.-F., Yu, S.-G., Zheng, H., & Chen, M. (2022) · doi:10.3389/fphar.2022.853011.s002
Metadata
- Authors
- Gayathri, R., Aruna, T., Malar, S., Shilpa, B., & Dhanasekar, K. R.
- Affiliations
- Government Kilpauk Medical College (IN)
- Corresponding author
- Dhanasekar, Karukkupalayam Ramasamy
- Venue
- International Journal of Colorectal Disease
- Published
- 2019-12-05
- Volume
- 35
- Issue
- 1
- Pages
- 139-145
- ISSN
- 0179-1958 (ISSN-L)
- 1432-1262
- OpenAlex
- W2993080746
- Cited by
- 33
- References
- 17
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 2
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- International Journal of Colorectal Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- irritable bowel syndrome, probiotics, adjunctive therapy, abdominal pain, stool consistency, diarrhea-predominant irritable bowel syndrome, irritable bowel syndrome with constipation, IBS-M, health-related quality of life, anti-inflammatory activity, analgesic activity
- MeSH terms
- Adult, Feces, Female, Humans, Male, Saccharomyces cerevisiae, Abdominal Pain, Treatment Outcome, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.